Form 4: Astera Labs Executive Sanjay Gajendra Sells Shares Under 10b5-1 Trading Plan

Sanjay Gajendra, President and COO of Astera Labs, sold shares of the company's common stock on September 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 17, 2024, Sanjay Gajendra, President and COO of Astera Labs, executed sales of the company's common stock.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Gajendra sold 42,649 shares at an average price of $45.3595, 5,652 shares at an average price of $46.1095, 14,200 shares at an average price of $45.0929, and 14,200 shares at an average price of $45.0883.
• Following these transactions, Gajendra directly owns 2,704,335 shares.
• He also indirectly owns 7,001,197 shares through Trust 1, 855,000 shares through Trust 2, and 855,000 shares through Trust 3.
• Gajendra disclaims beneficial ownership of the shares held in the trusts, except to the extent of any pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as the sales were pre-planned.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The market will likely interpret this as a standard transaction unless the volume is unusually high or coincides with other significant news.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, but is unlikely to have a significant impact due to the pre-planned nature of the sales.

Key Dates